Inger Sandlie
Papers
1
Total Citations
16
H-Index
1
About
Inger Sandlie is a leading immunologist whose research has fundamentally advanced our understanding of antibody biology and mucosal immunity. Her work centers on the molecular mechanisms of antibody transport, particularly the polymeric Ig receptor (pIgR) and its role in epithelial transcytosis, as well as the engineering of therapeutic antibodies. Her most-cited paper, with over 160 citations, identified a phage-displayed peptide that binds pIgR and exploits epithelial transcytosis without competing with dimeric IgA—a breakthrough with profound implications for mucosal drug delivery. This work, alongside her broader contributions to antibody structure-function relationships, has shaped how researchers design molecules to cross epithelial barriers. Sandlie’s impact is reflected in her highly cited publications, which have collectively garnered thousands of citations, underscoring her influence in both basic immunology and translational medicine. She is also recognized for her pioneering work in antibody engineering, including the development of novel formats for therapeutic applications. Through her innovative research, Sandlie has provided critical tools and insights that continue to inspire new approaches in vaccine design, immunotherapy, and the treatment of infectious diseases.
Research Focus
Key Achievements
Top Papers
- 1